Get the Stockscreener App
5.05
1.81%
0.09
Trisalus Life Sciences Inc stock is traded at $5.05, with a volume of 166.43K.
It is up +1.81% in the last 24 hours and up +12.22% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$4.96
Open:
$4.91
24h Volume:
166.43K
Relative Volume:
1.87
Market Cap:
$251.83M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.8821
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
+10.99%
1M Performance:
+12.22%
6M Performance:
-12.48%
1Y Performance:
-9.66%
1-Day Range:
$4.8996
$5.145
1-Week Range:
$4.1715
$5.28
52-Week Range:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.05 | 242.35M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
Best data tools to analyze TriSalus Life Sciences Inc. Equity Warrant stockWall Street Watch & Daily Profit Focused Screening - Newser
Key resistance and support levels for TriSalus Life Sciences Inc. Equity WarrantEarnings Performance Report & AI Driven Stock Movement Reports - Newser
What the charts say about TriSalus Life Sciences Inc. Equity Warrant todaySwing Trade & Reliable Trade Execution Plans - Newser
How to track smart money flows in TriSalus Life Sciences Inc.Market Sentiment Review & Safe Capital Allocation Plans - Newser
Volatility clustering patterns for TriSalus Life Sciences Inc. Equity Warrant2025 Biggest Moves & Real-Time Volume Triggers - Newser
What moving averages say about TriSalus Life Sciences Inc.Portfolio Update Report & Verified Technical Trade Signals - Newser
Real time pattern detection on TriSalus Life Sciences Inc. Equity Warrant stockEarnings Growth Summary & Free Verified High Yield Trade Plans - Newser
When is the best time to exit TriSalus Life Sciences Inc. Equity WarrantJuly 2025 Weekly Recap & Weekly Breakout Stock Alerts - Newser
Tick level data insight on TriSalus Life Sciences Inc. Equity Warrant volatilityExit Point & Daily Technical Forecast Reports - Newser
Can technical indicators confirm TriSalus Life Sciences Inc. Equity Warrant’s reversalJuly 2025 Movers & Safe Capital Growth Trade Ideas - Newser
Institutional scanner results for TriSalus Life Sciences Inc. Equity WarrantJuly 2025 Market Mood & Real-Time Chart Pattern Alerts - Newser
Signal strength of TriSalus Life Sciences Inc. Equity Warrant stock in tech scannersWeekly Risk Report & Verified Entry Point Signals - Newser
Published on: 2025-08-19 21:54:38 - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.Gold Moves & Technical Entry and Exit Tips - Newser
News impact scoring models applied to TriSalus Life Sciences Inc. Equity WarrantWeekly Market Summary & Reliable Breakout Stock Forecasts - Newser
Is it time to cut losses on TriSalus Life Sciences Inc. Equity WarrantInsider Selling & Daily Market Momentum Tracking - Newser
Chart based analysis of TriSalus Life Sciences Inc. trendsExit Point & Fast Exit and Entry Trade Guides - Newser
Published on: 2025-08-19 16:17:42 - Newser
Using RSI to spot recovery in TriSalus Life Sciences Inc. Equity WarrantJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Tools to assess TriSalus Life Sciences Inc.’s risk profile2025 Big Picture & High Win Rate Trade Alerts - Newser
TriSalus Life Sciences Inc. Equity Warrant stock outlook for YEARJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser
What technical models suggest about TriSalus Life Sciences Inc.’s comebackRate Hike & Consistent Income Trade Ideas - Newser
Momentum divergence signals in TriSalus Life Sciences Inc. Equity Warrant chartTrade Risk Summary & Safe Entry Zone Identification - Newser
Published on: 2025-08-19 06:12:07 - Newser
Top chart patterns to watch in TriSalus Life Sciences Inc.2025 Stock Rankings & Free Real-Time Volume Trigger Notifications - Newser
Pattern recognition hints at TriSalus Life Sciences Inc. upsideBond Market & Long-Term Safe Investment Plans - Newser
Analyzing net buyer seller activity in TriSalus Life Sciences Inc. Equity WarrantWeekly Profit Recap & AI Optimized Trade Strategies - Newser
Combining machine learning predictions for TriSalus Life Sciences Inc.Weekly Profit Summary & AI Driven Stock Price Forecasts - Newser
TriSalus Life Sciences launches preferred stock exchange - MSN
Can TriSalus Life Sciences Inc. Equity Warrant rally from current levelsQuarterly Trade Summary & Risk Managed Investment Entry Signals - Newser
Critical Review: TriSalus Life Sciences (NASDAQ:TLSI) versus Senestech (NASDAQ:SNES) - Defense World
Applying big data sentiment scoring on TriSalus Life Sciences Inc. Equity WarrantLayoff News & Free Technical Confirmation Trade Alerts - Newser
Using economic indicators to assess TriSalus Life Sciences Inc. Equity Warrant potentialJuly 2025 Earnings & Real-Time Sentiment Analysis - Newser
Analyzing recovery setups for TriSalus Life Sciences Inc. investors2025 Retail Activity & Weekly Stock Breakout Alerts - Newser
How to build a custom watchlist for TriSalus Life Sciences Inc.Market Activity Recap & Risk Managed Trade Strategies - Newser
Applying sector rotation models to TriSalus Life Sciences Inc. Equity Warrant2025 Price Momentum & Scalable Portfolio Growth Methods - Newser
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Trisalus Life Sciences Inc Stock (TLSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):